Insilico medicine is a branch of medical science that deals with the application of computer simulation and modeling to various aspects of medicine. It includes the use of computers for drug discovery, disease diagnosis, patient care, and other medical purposes.
The term “in silico” is derived from the Latin phrase meaning “on computer”. It refers to the fact that all calculations and simulations are carried out on computers. This type of research is also known as in silico experimentation or computer-aided drug design (CADD).
Insilico medicine has its roots in the early days of computing, when scientists used simple computer programs to model biological systems. One of the earliest examples was a program developed by British chemist Dorothy Hodgkin in the early 1950s to predict the structure of proteins. Since then, advances in computing power and software development have enabled more complex models to be created.
Today, insilico medicine is an important tool in many areas of healthcare. It is used for developing new drugs, understanding how diseases develop and progress, designing personalized treatments, and even making decisions about which patients should receive certain types of care. In addition, as healthcare data becomes increasingly available online, insilico medicine techniques are being used to mine this data for new insights into human health.